Inhibrx Biosciences (INBX)

Inhibrx Biosciences on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances).

Download CSV

3.4M

Short interest

settlement 2026-09-30

11.8

Days to cover

+3.5 days vs prior

73.8%

Short share of volume

2026-10-22

397

Fails to deliver

settlement 2026-09-22

Fri 13 Nov

Next earnings

estimated date

2 people

Insiders buying, 30 days

$2.3M combined, latest 2026-10-14

$6.1M

Insider flow, 90 days

20 buys, 5 sells

As of 2026-10-22.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 30 September 2026, short interest in INBX is 3,432,642 shares, up 134,899 shares over the last month. Over the last 48 readings it ranged from 524,531 shares (30 September 2025) to 3,447,032 shares (30 June 2026). The latest reading sits at the top of that range. At the reported average volume of 290K shares a day that is 11.8 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/inbx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-09-30	3,432,642	+1.1%	290,359	11.82
2026-09-15	3,393,511	+2.9%	408,480	8.31
2026-08-31	3,297,743	+2.6%	317,496	10.39
2026-08-14	3,215,230	-3.8%	223,490	14.39
2026-07-31	3,341,210	-2.7%	213,594	15.64
2026-07-15	3,433,872	-0.4%	379,873	9.04
2026-06-30	3,447,032	+4.5%	347,713	9.91
2026-06-15	3,299,693	+3.8%	321,930	10.25
2026-05-29	3,179,335	+8.4%	341,252	9.32
2026-05-15	2,932,658	+7.3%	654,241	4.48
2026-04-30	2,733,548	+27.9%	687,984	3.97
2026-04-15	2,136,978	+0.8%	246,794	8.66
2026-03-31	2,119,421	+13.7%	247,014	8.58
2026-03-13	1,864,224	+7.9%	179,297	10.40
2026-02-27	1,727,284	-0.4%	153,759	11.23
2026-02-13	1,734,575	-0.2%	156,185	11.11
2026-01-30	1,737,927	+5.3%	243,093	7.15
2026-01-15	1,650,847	-3.6%	167,640	9.85
2025-12-31	1,712,725	+63.1%	277,794	6.17
2025-12-15	1,049,942	-20.5%	196,978	5.33
2025-11-28	1,321,190	+16.3%	259,844	5.08
2025-11-14	1,136,139	+10.7%	346,540	3.28
2025-10-31	1,026,055	+92.6%	1,026,597	1.00
2025-10-15	532,661	+1.6%	161,268	3.30
2025-09-30	524,531	-27.3%	149,004	3.52
2025-09-15	721,500	-8.9%	95,876	7.53
2025-08-29	792,236	+5.9%	125,181	6.33
2025-08-15	748,150	+10.5%	85,060	8.80
2025-07-31	676,803	-24.7%	119,568	5.66
2025-07-15	898,441	+26.4%	163,482	5.50
2025-06-30	710,674	-9.2%	95,526	7.44
2025-06-13	782,491	+10.7%	67,019	11.68
2025-05-30	706,979	-6.5%	98,300	7.19
2025-05-15	756,289	+3.6%	101,861	7.42
2025-04-30	729,920	-3.6%	87,425	8.35
2025-04-15	757,291	-18.9%	183,809	4.12
2025-03-31	934,225	-2.2%	80,702	11.58
2025-03-14	955,403	-19.4%	120,146	7.95
2025-02-28	1,186,159	-7.2%	74,889	15.84
2025-02-14	1,278,420	+4.7%	73,119	17.48
2025-01-31	1,221,041	-5.2%	113,246	10.78
2025-01-15	1,287,370	+3.4%	79,902	16.11
2024-12-31	1,245,172	+3.4%	77,342	16.10
2024-12-13	1,204,251	+10.5%	73,703	16.34
2024-11-29	1,089,621	+5.9%	77,717	14.02
2024-11-15	1,028,479	+5.3%	77,633	13.25
2024-10-31	976,671	+9.1%	41,812	23.36
2024-10-15	895,657	+20.6%	93,233	9.61

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 22 October 2026, the short share of INBX volume is 73.8%, up 13.9 points over the last five sessions. Over the last 30 readings it ranged from 39.6% (5 October 2026) to 84.1% (21 September 2026). The latest reading is 11.4 points above the 30-session average of 62.4%, on 112K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-10-22	83K	112K	73.8%	0
2026-10-21	75K	101K	73.9%	0
2026-10-20	32K	48K	66.9%	0
2026-10-19	35K	68K	51.2%	0
2026-10-16	42K	59K	71.6%	0
2026-10-15	48K	80K	59.9%	3,227
2026-10-14	62K	115K	53.6%	84
2026-10-13	69K	113K	61.5%	256
2026-10-12	35K	67K	52.5%	0
2026-10-09	20K	27K	73.0%	0
2026-10-08	32K	67K	47.8%	0
2026-10-07	36K	56K	64.1%	0
2026-10-06	34K	60K	56.9%	30
2026-10-05	35K	87K	39.6%	1,559
2026-10-02	61K	84K	73.4%	0
2026-10-01	58K	87K	66.6%	0
2026-09-30	66K	85K	77.8%	0
2026-09-29	29K	64K	45.6%	0
2026-09-28	33K	52K	64.3%	0
2026-09-25	37K	59K	62.5%	0
2026-09-24	45K	91K	49.9%	4,240
2026-09-23	107K	147K	72.5%	800
2026-09-22	85K	105K	80.4%	112
2026-09-21	72K	86K	84.1%	84
2026-09-18	48K	78K	60.9%	0
2026-09-17	39K	67K	57.6%	0
2026-09-16	62K	116K	53.9%	0
2026-09-15	66K	96K	69.2%	0
2026-09-14	36K	81K	43.7%	0
2026-09-11	51K	81K	63.3%	0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 22 September 2026, the fails-to-deliver balance in INBX is 397 shares, down 30,637 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (20 August 2026) to 31,034 shares (15 September 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-09-22	397	$112.04	$44K
2026-09-15	31,034	$110.47	$3.4M
2026-08-27	61	$125.34	$8K
2026-08-20	2	$101.48	$203
2026-08-14	14	$97.01	$1K
2026-07-17	98	$89.07	$9K
2026-07-09	1,052	$97.10	$102K
2026-06-30	2,433	$95.50	$232K
2026-06-25	21	$95.14	$2K
2026-06-24	2,471	$92.91	$230K
2026-06-23	222	$93.30	$21K
2026-06-22	733	$93.05	$68K
2026-06-18	135	$94.20	$13K
2026-06-16	38	$93.51	$4K
2026-06-11	2,360	$89.47	$211K
2026-06-08	1,930	$87.01	$168K
2026-06-02	59	$99.29	$6K
2026-05-19	106	$105.80	$11K
2026-05-18	2,495	$108.64	$271K
2026-04-27	9,973	$129.06	$1.3M
2026-04-23	920	$115.09	$106K
2026-04-13	13	$75.27	$979
2026-04-10	20	$75.75	$2K
2026-04-09	16	$67.13	$1K
2026-04-02	1,214	$67.05	$81K
2026-03-23	108	$60.92	$7K
2026-03-17	21	$69.26	$1K
2026-03-06	11,122	$70.66	$786K
2026-03-03	90	$77.49	$7K
2026-02-20	35	$81.08	$3K

Insider trades

SEC Form 4, newest first. JSON

Over the last 90 days INBX insiders reported 20 open-market buys ($6.3M) against 5 sells ($279K), so the dollar flow leans toward buying. Latest filing: Lappe Mark (Chief Executive Officer) on 2026-10-14.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-10-14	Lappe Mark	Chief Executive Officer	Buy	100	$85.76	$9K	170K
2026-10-14	Lappe Mark	Chief Executive Officer	Buy	2K	$85.00	$208K	170K
2026-10-14	Lappe Mark	Chief Executive Officer	Buy	2K	$84.07	$206K	167K
2026-10-14	Lappe Mark	Chief Executive Officer	Buy	100	$85.76	$9K	746K
2026-10-14	Lappe Mark	Chief Executive Officer	Buy	2K	$85.00	$210K	745K
2026-10-14	Lappe Mark	Chief Executive Officer	Buy	2K	$84.07	$208K	743K
2026-09-28	Lappe Mark	Chief Executive Officer	Buy	3K	$101.70	$305K	741K
2026-09-28	Lappe Mark	Chief Executive Officer	Buy	2K	$98.88	$148K	738K
2026-09-25	Lappe Mark	Chief Executive Officer	Buy	2K	$99.60	$217K	736K
2026-09-25	Lappe Mark	Chief Executive Officer	Buy	3K	$98.87	$329K	734K
2026-09-23	Kayyem Jon Faiz	Director	Buy	5K	$100.00	$500K	434K
2026-09-16	Kayyem Jon Faiz	Director	Buy	5K	$100.00	$500K	429K
2026-09-15	MANHARD KIMBERLY	Director	Sell	500	$105.05	$53K	8K
2026-09-14	MANHARD KIMBERLY	Director	Sell	500	$110.26	$55K	8K
2026-09-11	MANHARD KIMBERLY	Director	Sell	500	$111.78	$56K	9K
2026-09-09	MANHARD KIMBERLY	Director	Sell	500	$115.80	$58K	9K
2026-09-08	MANHARD KIMBERLY	Director	Sell	500	$115.14	$58K	10K
2026-09-08	Kayyem Jon Faiz	Director	Buy	5K	$113.52	$568K	424K
2026-09-08	Lappe Mark	Chief Executive Officer	Buy	10K	$112.28	$1.1M	731K
2026-09-08	Lappe Mark	Chief Executive Officer	Buy	1K	$111.88	$136K	721K
2026-09-08	Lappe Mark	Chief Executive Officer	Buy	500	$108.23	$54K	720K
2026-09-08	Lappe Mark	Chief Executive Officer	Buy	1K	$107.12	$118K	719K
2026-09-08	Lappe Mark	Chief Executive Officer	Buy	7K	$100.64	$665K	718K
2026-09-08	Lappe Mark	Chief Executive Officer	Buy	6K	$99.29	$585K	711K
2026-09-08	FORSYTH DOUGLAS	Director	Buy	3K	$114.65	$287K	227K
2025-10-07	Viking Global Opportunities Parent GP LLC	TenPercentOwner	Sell	25K	$32.25	$808K	103K
2025-10-07	Viking Global Opportunities Parent GP LLC	TenPercentOwner	Sell	309K	$32.25	$10.0M	1.3M
2025-10-07	Viking Global Opportunities Parent GP LLC	TenPercentOwner	Sell	16K	$32.25	$526K	67K
2025-10-07	VIKING GLOBAL INVESTORS LP	10% owner	Sell	25K	$32.25	$808K	103K
2025-10-07	VIKING GLOBAL INVESTORS LP	10% owner	Sell	16K	$32.25	$526K	67K
2025-10-07	VIKING GLOBAL INVESTORS LP	10% owner	Sell	309K	$32.25	$10.0M	1.3M
2025-03-27	Kayyem Jon Faiz	Director	Gift	90K	$0.00	$0	419K
2024-12-16	Kayyem Jon Faiz	Director	Gift	250K	$0.00	$0	250K
2024-12-16	Kayyem Jon Faiz	Director	Gift	500K	$0.00	$0	509K
2024-12-16	Kayyem Jon Faiz	Director	Gift	250K	$0.00	$0	250K
2024-12-06	Kayyem Jon Faiz	Director	Gift	52K	$0.00	$0	1.0M
2024-11-20	Kayyem Jon Faiz	Director	Buy	19K	$14.19	$266K	70K
2024-11-20	Kayyem Jon Faiz	Director	Buy	19K	$14.19	$266K	70K
2024-11-19	Kayyem Jon Faiz	Director	Buy	35K	$14.23	$496K	51K
2024-11-19	Kayyem Jon Faiz	Director	Buy	35K	$14.23	$496K	51K
2024-10-03	Vuori Kristiina MD	Director	Buy	7K	$15.00	$100K	20K
2024-09-16	Lappe Mark	Chief Executive Officer	Buy	13K	$17.13	$223K	706K
2024-09-12	Lappe Mark	Chief Executive Officer	Buy	27K	$15.05	$406K	693K
2024-09-11	Vuori Kristiina MD	Director	Buy	6K	$15.07	$97K	14K
2024-09-10	Lappe Mark	Chief Executive Officer	Buy	9K	$15.19	$129K	666K
2024-09-10	Vuori Kristiina MD	Director	Buy	179	$15.00	$3K	7K
2024-09-09	Lappe Mark	Chief Executive Officer	Buy	10K	$15.21	$144K	657K
2024-09-06	Lappe Mark	Chief Executive Officer	Buy	26K	$15.29	$398K	648K
2024-09-03	Lappe Mark	Chief Executive Officer	Buy	15K	$15.66	$239K	160K
2024-09-03	Lappe Mark	Chief Executive Officer	Buy	5K	$16.31	$77K	165K
2024-08-30	Lappe Mark	Chief Executive Officer	Buy	10K	$14.02	$140K	145K
2024-08-29	Vuori Kristiina MD	Director	Buy	7K	$14.00	$100K	7K
2024-08-29	Lappe Mark	Chief Executive Officer	Buy	10K	$14.03	$140K	135K
2024-08-28	MANHARD KIMBERLY	Director	Buy	10K	$13.98	$140K	10K
2024-08-23	FORSYTH DOUGLAS	Director	Buy	60K	$14.07	$842K	225K
2024-08-22	FORSYTH DOUGLAS	Director	Buy	15K	$12.89	$196K	165K
2024-08-21	Lappe Mark	Chief Executive Officer	Buy	13K	$12.93	$167K	55K
2024-08-20	Lappe Mark	Chief Executive Officer	Buy	27K	$12.97	$351K	42K
2024-06-24	Kayyem Jon Faiz	Director	Gift	10K	$0.00	$0	16K
2024-06-24	Kayyem Jon Faiz	Director	Gift	89K	$0.00	$0	1.1M
2024-06-24	Kayyem Jon Faiz	Director	Gift	10K	$0.00	$0	16K
2024-06-05	Kayyem Jon Faiz	Director	Buy	49K	$17.23	$849K	1.1M
2024-06-05	Kayyem Jon Faiz	Director	Buy	8K	$17.89	$148K	1.2M
2024-06-04	Kayyem Jon Faiz	Director	Buy	24K	$18.24	$433K	1.1M
2024-06-04	Kayyem Jon Faiz	Director	Buy	65K	$17.44	$1.1M	1.1M
2024-06-03	Kayyem Jon Faiz	Director	Buy	47K	$16.61	$777K	923K
2024-06-03	Kayyem Jon Faiz	Director	Buy	81K	$17.90	$1.4M	1.0M
2024-05-31	Kayyem Jon Faiz	Director	Buy	70K	$16.14	$1.1M	876K
2024-05-29	Inhibrx, Inc.	TenPercentOwner	Other transaction	13.3M	price not stated in the filing	not stated	1.2M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Planned sales (Form 144)

Newest first. JSON

5 Form 144 notices on file for INBX worth $279K at the prices reported; 5 in the last 90 days worth $279K. Latest: MANHARD KIMBERLY filed on 2026-09-15 to sell 500 shares ($53K) from 2026-09-15.

Filed	Seller	Shares	Market value	Of outstanding	Sale from	Broker
2026-09-15	MANHARD KIMBERLYDirector	500	$53K	0.003%	2026-09-15	Fidelity Brokerage Services LLC
2026-09-14	MANHARD KIMBERLYDirector	500	$55K	0.003%	2026-09-14	Fidelity Brokerage Services LLC
2026-09-11	MANHARD KIMBERLYDirector	500	$56K	0.003%	2026-09-11	Fidelity Brokerage Services LLC
2026-09-09	MANHARD KIMBERLYDirector	500	$58K	0.003%	2026-09-09	Fidelity Brokerage Services LLC
2026-09-08	MANHARD KIMBERLYDirector	500	$58K	0.003%	2026-09-08	Fidelity Brokerage Services LLC

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

16 holders report 5% or more of INBX in their latest filing, all on Schedule 13G (passive). The largest reported stake is Perceptive Life Sciences Master Fund, Ltd. at 10.0% of the class (1,489,443 shares), filed 2026-08-14 for an event on 2026-06-30.

Filed	Form	Holder	Shares	Of class	Event
2026-08-14	13G	Schonfeld Strategic Advisors LLCinvestment adviser	782K	5.3%	2026-06-30
2026-08-14	13G/Ano. 2	Perceptive Life Sciences Master Fund, Ltd.corporation	1.5M	10.0%	2026-06-30
2026-08-14	13G/Ano. 2	Perceptive Advisors LLCinvestment adviser	1.5M	10.0%	2026-06-30
2026-08-14	13G/Ano. 2	Joseph Edelmanindividual	1.5M	10.0%	2026-06-30
2026-08-14	13G/Ano. 3	Shabet Rose Sharonindividual	1.4M	9.3%	2026-06-30
2026-08-14	13G/Ano. 3	VIKING GLOBAL INVESTORS LPpartnership	1.4M	9.3%	2026-06-30
2026-08-14	13G/Ano. 3	Viking Global Opportunities Parent GP LLCother entity	1.4M	9.3%	2026-06-30
2026-08-14	13G/Ano. 3	HALVORSEN OLE ANDREASindividual	1.4M	9.3%	2026-06-30
2026-08-14	13G/Ano. 3	Viking Global Opportunities GP LLCother entity	1.3M	8.7%	2026-06-30
2026-08-14	13G/Ano. 3	Viking Global Opportunities Portfolio GP LLCother entity	1.3M	8.4%	2026-06-30
2026-08-14	13G/Ano. 3	Viking Global Opportunities Illiquid Investments Sub-Master LPpartnership	1.3M	8.4%	2026-06-30
2026-08-14	13G/Ano. 3	Viking Global Opportunities Drawdown Portfolio GP LLCother entity	80K	0.5%	2026-06-30
2026-08-14	13G/Ano. 3	Viking Global Opportunities Drawdown GP LLCother entity	80K	0.5%	2026-06-30
2026-08-14	13G/Ano. 3	Viking Global Opportunities Drawdown (Aggregator) LPpartnership	80K	0.5%	2026-06-30
2026-08-14	13G/Ano. 3	KAVRA 104 LLCother entity	52K	0.4%	2026-06-30
2026-08-03	13G	BANK OF AMERICA CORP /DE/parent holding company	857K	5.9%	2026-06-30
2026-02-17	13G/Ano. 1	Ott David C.individual	1.5M	10.0%	2025-12-31
2026-02-11	13G	Morgan Stanleyparent holding company, corporation	1.2M	7.9%	2025-12-31
2026-02-11	13G	Morgan Stanley Capital Services LLCbroker-dealer, corporation	918K	6.3%	2025-12-31
2026-01-21	13G	BlackRock, Inc.parent holding company	768K	5.3%	2025-12-31

13F holders

Tracked managers holding INBX at their latest 13F. JSON

6 of the 30 tracked managers held INBX at their latest 13F, $132.0M in total at quarter-end prices. Viking Global Investors is the largest at $106.5M (0.3% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 3 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Viking Global Investors	2026-06-30	1.1M	$106.5M	0.30%	-314K
Millennium Management	2026-06-30	147K	$13.9M	0.01%	-181K
Renaissance Technologies	2026-06-30	62K	$5.9M	0.01%	+12K
Point72 Asset Management	2026-06-30	26K	$2.5M	0.00%	new
D. E. Shaw & Co.	2026-06-30	22K	$2.1M	0.00%	-55K
AQR Capital Management	2026-06-30	11K	$1.1M	0.00%	+3K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Inhibrx Biosciences in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Inhibrx Biosciences (INBX), SEC CIK 2007919, listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances). The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-22.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-22.JSON and CSV
Planned sales: SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-15.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-13.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-14.JSON and CSV
Company record: EDGAR filing index for CIK 2007919Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as biological products, (no diagnostic substances)

Other company pages

Datasets

Frequently Asked Questions

How much of INBX is sold short?

3,432,642 shares were held short at the 2026-09-30 settlement, 11.8 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is INBX's daily short volume?

On 2026-10-22, 82,837 of the 112,260 INBX shares reported to FINRA were sold short, 73.8% of the day's reported volume. Short volume is a flow for one day, not a position.

Does INBX have fails to deliver?

The SEC's latest file shows 397 INBX shares failed to deliver at settlement 2026-09-22. Fails are reported per settlement date and published twice a month with a lag.

Are INBX insiders buying or selling?

Have INBX insiders filed to sell?

5 Form 144 notices on file for INBX worth $279K at the prices reported; 5 in the last 90 days worth $279K. Latest: MANHARD KIMBERLY filed on 2026-09-15 to sell 500 shares ($53K) from 2026-09-15.

Who owns 5% or more of INBX?

Which tracked 13F managers own INBX?

6 of the 30 tracked 13F managers held INBX shares at their latest filing, $132.0M in all. The largest: Andreas Halvorsen's Viking Global Investors (1.1M shares, $106.5M), Izzy Englander's Millennium Management (147K shares, $13.9M), Renaissance Technologies (62K shares, $5.9M), Steve Cohen's Point72 Asset Management (26K shares, $2.5M), D. E. Shaw & Co. (22K shares, $2.1M), Cliff Asness's AQR Capital Management (11K shares, $1.1M).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.